June 3, 2016: The perceived role of invasive cardiac services, especially percutaneous transluminal interventions (PCI), has changed significantly over the past 5-10 years.  New healthcare payment models will apply new pressures to assure that only procedures of high value are performed.  I will review changes in the use of, and perceptions about, invasive cardiac services over the past several decades, and explore how new models of care management may help optimize use of these expensive but useful services.

Dr. Garratt joined Christiana Health System as Associate Director, Center for Heart and Vascular Health in 2015. He also serves as Director, CV Quality and Safety, and as Director, CV Research.  He is highly engaged in the Society for Cardiac Angiography and Intervention (SCAI), a national society with a focus on quality of invasive CV care, participating in numerous activities including Quality, Steering and Executive Committees.